Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
4.920
-1.230 (-20.00%)
May 13, 2025, 4:00 PM - Market closed
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 279 employees as of December 31, 2024. The number of employees decreased by 46 or -14.15% compared to the previous year.
Employees
279
Change (1Y)
-46
Growth (1Y)
-14.15%
Revenue / Employee
$509,412
Profits / Employee
-$224,093
Market Cap
42.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KPTI News
- 17 hours ago - These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results - Benzinga
- 1 day ago - Karyopharm Therapeutics Inc. (KPTI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification - PRNewsWire
- 5 days ago - Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025 - PRNewsWire
- 12 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC - PRNewsWire
- 2 months ago - Karyopharm Announces 1-for-15 Reverse Stock Split - PRNewsWire
- 2 months ago - Karyopharm Therapeutics Inc. (KPTI) Q4 2024 Earnings Call Transcript - Seeking Alpha